Literature DB >> 25128260

Auto-fluorescence of the bone and its use for delineation of bone necrosis.

O Ristow1, C Pautke2.   

Abstract

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a challenging complication of long-term bisphosphonate treatment. Currently, the drawback in the surgical management of BRONJ is the difficulty distinguishing between viable and necrotic bone. Intraoperative bone fluorescence induced by tetracyclines has been shown to be a valuable aid to overcome this problem. In this technical note we report the finding that viable bone is auto-fluorescent using the VELscope Vx fluorescence lamp. Necrotic bone shows an altered fluorescence pattern (pale or no fluorescence). Thus it is suggested that auto-fluorescence of bone might be of similar use during the surgical therapy of BRONJ.
Copyright © 2014 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BRONJ; DRONJ; VELscope Vx; auto-fluorescence; bone; necrosis of the jaw; osteonecrosis; therapy

Mesh:

Substances:

Year:  2014        PMID: 25128260     DOI: 10.1016/j.ijom.2014.07.017

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  9 in total

1.  Carcinoma of the lip five years after bone marrow transplantation.

Authors:  M Ardore; M Berrone; G Marchitto; S Gandolfo; M Pentenero
Journal:  Ann Stomatol (Roma)       Date:  2015-12-01

2.  Use of a generic violet light in the surgical management of medication-related osteonecrosis of the jaws: a technical note.

Authors:  Caroline Ballardin; Cecilia Luiz Pereira-Stabile; Glaykon Alex Vitti Stabile
Journal:  Oral Maxillofac Surg       Date:  2018-09-01

Review 3.  Progresses in Fluorescence Imaging Guidance for Bone and Soft Tissue Sarcoma Surgery.

Authors:  Zhenyi Chen; Huayi Huang; Siyuan He; Yi Wang; Lin Cai; Yuanlong Xie
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

4.  Fluorescence-guided surgery for osteoradionecrosis of the jaw: a retrospective study.

Authors:  Suad Aljohani; Riham Fliefel; Teresa Franziska Brunner; Aristeidis Chronopoulos; Nada Binmadi; Sven Otto
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

5.  The Effectiveness of the Low-Level Laser, Antibiotic and Surgical Therapy in the Treatment of Medication-Related Osteonecrosis of the Jaws: A Case Report.

Authors:  Maria Del Pilar Rodríguez-Sánchez; Cristian Statkievicz; João Martins de Mello-Neto; Luan Felipe Toro; Ana Paula Farnezzi Bassi; Valdir Gouveia Garcia; Letícia Helena Theodoro; Edilson Ervolino
Journal:  J Lasers Med Sci       Date:  2020-01-18

Review 6.  Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ).

Authors:  Britt-Isabelle Berg; Andreas A Mueller; Marcello Augello; Scott Berg; Claude Jaquiéry
Journal:  Dent J (Basel)       Date:  2016-09-02

7.  Differences between auto-fluorescence and tetracycline-fluorescence in medication-related osteonecrosis of the jaw-a preclinical proof of concept study in the mini-pig.

Authors:  Oliver Ristow; Dirk Nehrbass; Stephan Zeiter; Daniel Arens; Julius Moratin; Christoph Pautke; Jürgen Hoffmann; Christian Freudlsperger; Sven Otto
Journal:  Clin Oral Investig       Date:  2020-05-22       Impact factor: 3.573

Review 8.  The Therapeutic Effectiveness Using Fluorescence-Guided Surgery for MRONJ.

Authors:  Hongyuan Huang; Ning Zhao; Qingxiang Li; Qiao Qiao; Jianya Zhang; Chuanbin Guo; Yuxing Guo
Journal:  Biomed Res Int       Date:  2022-09-17       Impact factor: 3.246

9.  Perspective on optical imaging for functional assessment in musculoskeletal extremity trauma surgery.

Authors:  Ida L Gitajn; Gerard P Slobogean; Eric R Henderson; Arvind G von Keudell; Mitchel B Harris; John A Scolaro; Nathan N O'Hara; Jonathan T Elliott; Brian W Pogue; Shudong Jiang
Journal:  J Biomed Opt       Date:  2020-08       Impact factor: 3.170

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.